Home> Products> dpp 4 inhibitor teneligliptin with metformin combo

{ "products": [ { "_id": "69afcdd7726d81b4833817a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin linagliptin", "description": "Advanced Combination Therapy with Metformin and Linagliptin for Effective Blood Sugar Control\n\nManaging type 2 diabetes requires consistent care, the right medication, and lifestyle management to maintain healthy blood glucose levels. Modern diabetes treatment often uses combination therapies that work through different mechanisms to provide better control and long-term health benefits. LINALIGOLD M 2.5/1000 is a scientifically formulated anti-diabetic medication that combines Metformin (1000 mg) and Linagliptin (2.5 mg) to help manage blood sugar levels effectively in adults with type 2 diabetes mellitus.\n\nThis dual-action tablet is designed to improve glycemic control when diet and exercise alone are not sufficient. By targeting different pathways involved in glucose regulation, LINALIGOLD M 2.5/1000 helps maintain stable blood sugar levels, supports metabolic health, and reduces the risk of diabetes-related complications.\n\nProduct Description\n\nLINALIGOLD M 2.5/1000 is a combination anti-diabetic medication that brings together two well-established drugs used in diabetes management: Metformin, a biguanide that reduces glucose production in the liver and improves insulin sensitivity, and Linagliptin, a DPP-4 inhibitor that enhances the body’s natural ability to regulate blood sugar levels.\n\nThis powerful combination works synergistically to control blood glucose levels throughout the day. While Metformin helps decrease the amount of sugar released into the bloodstream from the liver, Linagliptin increases the activity of incretin hormones, which stimulate insulin release when blood sugar levels are high.\n\nLINALIGOLD M 2.5/1000 is commonly prescribed for patients with type 2 diabetes mellitus who require improved glycemic control and who may not achieve adequate results with a single medication.\n\nKey Ingredients and Their Role\nMetformin (1000 mg)\n\nMetformin is one of the most widely used medications for the treatment of type 2 diabetes. It works primarily by:\n\nReducing glucose production in the liver\n\nImproving the body's sensitivity to insulin\n\nIncreasing glucose uptake by muscle cells\n\nReducing absorption of glucose from the intestines\n\nThese actions help lower fasting and post-meal blood sugar levels while supporting overall metabolic balance.\n\nLinagliptin (2.5 mg)\n\nLinagliptin belongs to a class of medications known as DPP-4 inhibitors. It works by increasing levels of incretin hormones in the body, which help regulate blood glucose levels. Its actions include:\n\nStimulating insulin release after meals\n\nReducing excessive glucose production by the liver\n\nLowering postprandial (after meal) blood sugar levels\n\nSupporting natural glucose regulation without causing sudden drops in blood sugar\n\nTogether, these two ingredients provide a comprehensive approach to diabetes management.\n\nUses of LINALIGOLD M 2.5/1000\n\nLINALIGOLD M 2.5/1000 is primarily used for the treatment and management of type 2 diabetes mellitus in adults. It helps maintain proper blood sugar levels and supports long-term metabolic health.\n\n1. Management of Type 2 Diabetes\n\nThis medication is prescribed to help control blood sugar levels in individuals diagnosed with type 2 diabetes when lifestyle modifications alone are not enough.\n\n2. Improvement of Glycemic Control\n\nThe dual mechanism of action helps regulate both fasting and post-meal blood glucose levels, improving overall glycemic control.\n\n3. Prevention of Diabetes Complications\n\nProper management of blood sugar levels helps reduce the risk of diabetes-related complications such as nerve damage, kidney problems, eye disorders, and cardiovascular disease.\n\n4. Support for Insulin Sensitivity\n\nMetformin helps improve the body's response to insulin, making it easier for cells to utilize glucose efficiently.\n\nKey Benefits of LINALIGOLD M 2.5/1000\n1. Dual Mechanism for Better Blood Sugar Control\n\nThe combination of Metformin and Linagliptin provides a two-way approach to controlling blood glucose levels by addressing multiple pathways involved in glucose metabolism.\n\n2. Helps Maintain Stable Blood Sugar Levels\n\nLINALIGOLD M 2.5/1000 helps regulate blood sugar throughout the day, including after meals when glucose levels tend to spike.\n\n3. Supports Natural Insulin Activity\n\nLinagliptin enhances the body's natural insulin response without forcing the pancreas to overwork.\n\n4. Reduces Risk of Blood Sugar Spikes\n\nBy controlling glucose production in the liver and improving insulin efficiency, the medication helps prevent sudden increases in blood sugar.\n\n5. Improves Overall Metabolic Health\n\nRegular use, along with proper diet and exercise, supports better metabolic balance and energy utilization in the body.\n\n6. Convenient Combination Therapy\n\nInstead of taking multiple medications separately, this fixed-dose combination simplifies diabetes management and improves treatment adherence.\n\n7. Lower Risk of Hypoglycemia\n\nCompared with some other diabetes medications, Linagliptin generally carries a lower risk of causing dangerously low blood sugar levels when used appropriately.\n\nHow to Use LINALIGOLD M 2.5/1000\n\nLINALIGOLD M 2.5/1000 should be taken exactly as prescribed by a healthcare professional.\n\nGeneral usage guidelines include:\n\nTake the tablet with food to reduce stomach discomfort.\n\nSwallow the tablet whole with water; do not crush or chew unless advised.\n\nFollow the dosage and schedule recommended by your doctor.\n\nMaintain a healthy diet and regular physical activity for optimal results.\n\nConsistent use is important for maintaining stable blood sugar levels.\n\nPossible Side Effects\n\nLike all medications, LINALIGOLD M 2.5/1000 may cause side effects in some individuals, although not everyone experiences them. Most side effects are mild and temporary as the body adjusts to the medication.\n\nCommon side effects may include:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nLoss of appetite\n\nMild headache\n\nFatigue\n\nLess common but possible side effects include:\n\nUpper respiratory symptoms such as cough or sore throat\n\nMild skin reactions\n\nVitamin B12 deficiency with long-term use of metformin\n\nRare but serious side effects may include:\n\nSevere allergic reactions\n\nLactic acidosis (a rare but serious condition associated with metformin)\n\nPancreatitis in rare cases related to DPP-4 inhibitors\n\nIf symptoms such as severe abdominal pain, unusual weakness, breathing difficulty, or persistent vomiting occur, medical attention should be sought immediately.\n\nPrecautions\n\nBefore taking LINALIGOLD M 2.5/1000, it is important to consult a healthcare professional, especially if you have:\n\nKidney disease\n\nLiver problems\n\nHeart conditions\n\nHistory of pancreatitis\n\nSevere infections or dehydration\n\nAdditional precautions include:\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about all medications you are currently taking.\n\nRegular blood sugar monitoring is recommended.\n\nLifestyle Recommendations for Better Results\n\nMedication works best when combined with healthy lifestyle practices. Patients using LINALIGOLD M 2.5/1000 are encouraged to:\n\nFollow a balanced diabetic-friendly diet\n\nEngage in regular physical activity\n\nMaintain a healthy body weight\n\nMonitor blood glucose levels regularly\n\nAttend routine medical checkups\n\nThese habits can significantly improve diabetes management and overall health.\n\nConclusion\nType 2 diabetes is a chronic condition that requires consistent and effective management to prevent long-term health complications. LINALIGOLD M 2.5/1000 offers a modern combination therapy that integrates the glucose-lowering effects of metformin with the incretin-enhancing action of Linagliptin, providing a comprehensive approach to blood sugar control.", "price": 154.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2323, "imageuri": "https://productimages.withfloats.com/actual/69afcdd9ea5ba715c39c99dc.png", "tileimageuri": "https://productimages.withfloats.com/tile/69afcdd9ea5ba715c39c99dc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-10T07:52:55.329Z", "updatedon": "2026-03-13T09:13:04.519Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/metformin-linagliptin/2323", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGOLD M 2.5/1000", "category": "DIABETIC RANGE", "tags": [ "metformin and linagliptin tablets for diabetes", "metformin linagliptin oral diabetes medication", "linagliptin 2.5 mg metformin 1000 mg tablet", "medicine for type 2 diabetes metformin linagliptin", "best medicine combination for type 2 diabetes", "blood sugar control medicine with metformin", "tablet for fasting and post meal sugar control", "how metformin linagliptin works for diabetes", "metformin linagliptin dosage for type 2 diabetes", "metformin linagliptin tablet price", "linagliptin metformin tablets wholesale price", "LINALIGOLD M metformin linagliptin tablet price", "LINALIGOLD M tablet for type 2 diabetes", "metformin linagliptin tablets india", "linagliptin metformin tablet manufacturer india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69a9837a9c219e2cff873568", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapagliflozin glimepiride metformin tablet", "description": "Composition: Dapagliflozin 10 mg + Glimepiride 2 mg + Metformin Hydrochloride 500 mg (Extended Release)\n\nManaging type 2 diabetes requires a balanced approach that includes proper medication, healthy lifestyle choices, and regular monitoring of blood sugar levels. Modern diabetes management often involves combination therapies that target blood glucose control through multiple mechanisms. One such effective combination medicine is GLIDAPAFLOZIN TRIO 2.\n\nThis medication contains three well-known antidiabetic agents—Dapagliflozin, Glimepiride, and Metformin Hydrochloride in an extended-release formulation. Together, these medicines work in different ways to help control blood sugar levels effectively in adults with type 2 diabetes.\n\nThis article provides a comprehensive overview of the product, its uses, benefits, possible side effects, and important information patients should know before using it.\n\nProduct Overview\n\nGLIDAPAFLOZIN TRIO 2 is a triple-combination oral antidiabetic tablet designed to help manage blood glucose levels in patients diagnosed with Type 2 Diabetes.\n\nEach tablet contains:\n\nDapagliflozin 10 mg\n\nGlimepiride 2 mg\n\nMetformin Hydrochloride 500 mg (Extended Release)\n\nThese ingredients work together to reduce high blood sugar levels through complementary mechanisms, helping patients achieve better glycemic control.\n\nCombination therapy like this is commonly recommended when a single medication alone is not sufficient to manage blood glucose levels.\n\nHow the Medicine Works\n\nThe three active ingredients in GLIDAPAFLOZIN TRIO 2 work through different pathways in the body.\n\n1. Dapagliflozin\n\nDapagliflozin belongs to a class of drugs known as SGLT2 inhibitors. It works by helping the kidneys remove excess glucose from the body through urine. This reduces blood sugar levels and may also provide additional cardiovascular and kidney benefits in some patients.\n\n2. Glimepiride\n\nGlimepiride stimulates the pancreas to release more insulin. Insulin is the hormone responsible for moving glucose from the bloodstream into cells where it can be used as energy.\n\n3. Metformin Hydrochloride (Extended Release)\n\nMetformin Hydrochloride helps lower blood sugar by reducing glucose production in the liver and improving insulin sensitivity in the body. The extended-release formulation ensures a steady release of the medicine over time, improving tolerance and effectiveness.\n\nTogether, these three medicines provide a comprehensive approach to blood sugar management.\n\nUses of GLIDAPAFLOZIN TRIO 2\n\nGLIDAPAFLOZIN TRIO 2 is primarily prescribed for the management of Type 2 Diabetes in adults.\n\nMain Uses\n\nBlood Sugar Control\nThe medication helps reduce high blood glucose levels in patients whose diabetes is not adequately controlled with diet, exercise, or single-drug therapy.\n\nImproving Insulin Function\nIt improves the body’s response to insulin and helps regulate glucose metabolism.\n\nPreventing Diabetes Complications\nProper blood sugar control reduces the risk of long-term complications such as nerve damage, kidney disease, vision problems, and cardiovascular issues.\n\nSupporting Weight and Metabolic Health\nThe presence of dapagliflozin may help some patients experience mild weight reduction and improved metabolic balance.\n\nKey Benefits\n\nThe combination of three effective antidiabetic agents offers several important benefits.\n\n1. Triple Mechanism Action\n\nThe medicine works through three complementary mechanisms, targeting multiple causes of high blood sugar.\n\n2. Better Glycemic Control\n\nPatients often achieve improved HbA1c levels compared to single-drug therapy.\n\n3. Reduced Risk of Long-Term Complications\n\nMaintaining controlled blood sugar levels helps prevent complications associated with diabetes.\n\n4. Convenient Single Tablet Therapy\n\nInstead of taking multiple medicines separately, patients can manage their treatment with a single tablet, improving medication adherence.\n\n5. Extended Release Technology\n\nThe extended-release formulation of Metformin Hydrochloride ensures gradual drug release, reducing stomach discomfort and improving patient tolerance.\n\n6. Improved Energy and Daily Functioning\n\nProper blood sugar control helps patients feel more energetic and maintain better overall health.\n\nPossible Side Effects\n\nLike all medications, GLIDAPAFLOZIN TRIO 2 may cause some side effects. However, not everyone experiences them.\n\nCommon Side Effects\n\nMild stomach discomfort\n\nNausea or vomiting\n\nDiarrhea\n\nHeadache\n\nIncreased urination\n\nLow blood sugar (hypoglycemia), especially when meals are skipped\n\nLess Common Side Effects\n\nUrinary tract infections\n\nDizziness or weakness\n\nMild dehydration\n\nRare but Serious Effects\n\nSevere hypoglycemia\n\nLactic acidosis (very rare but serious condition linked with metformin)\n\nAllergic reactions\n\nPatients should immediately consult a healthcare professional if they experience unusual symptoms such as severe weakness, difficulty breathing, or persistent stomach pain.\n\nPrecautions and Safety Advice\n\nBefore starting GLIDAPAFLOZIN TRIO 2, patients should inform their doctor if they have:\n\nKidney disease\n\nLiver problems\n\nHeart conditions\n\nHistory of severe dehydration\n\nAny known drug allergies\n\nPatients should also avoid skipping meals and maintain proper hydration to reduce the risk of low blood sugar.\n\nRegular monitoring of blood glucose levels is important while using this medication.\n\nLifestyle Tips for Better Results\n\nMedication alone cannot control diabetes. Patients should combine treatment with healthy habits.\n\nRecommended lifestyle practices include:\n\nMaintaining a balanced diabetic diet\n\nExercising regularly\n\nMonitoring blood sugar levels\n\nAvoiding excessive sugar and processed foods\n\nManaging stress levels\n\nGetting sufficient sleep\n\nThese lifestyle changes enhance the effectiveness of diabetes medications.\n\nConclusion\nManaging diabetes requires a consistent and comprehensive approach. Combination medicines like GLIDAPAFLOZIN TRIO 2 provide an effective solution for patients who need stronger glucose control than single-drug therapy can offer.", "price": 184.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2317, "imageuri": "https://productimages.withfloats.com/actual/69a9837cad119d5b47141190.png", "tileimageuri": "https://productimages.withfloats.com/tile/69a9837cad119d5b47141190.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-05T13:22:02.718Z", "updatedon": "2026-03-13T11:05:08.762Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/dapagliflozin-glimepiride-metformin-tablet/2317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN TRIO 2", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin glimepiride metformin tablet uses and dosage", "dapagliflozin glimepiride metformin combination tablet benefits", "dapagliflozin glimepiride metformin tablet side effects in adults", "dapagliflozin glimepiride metformin tablet how it works", "dapagliflozin glimepiride metformin tablet benefits for sugar control", "buy dapagliflozin glimepiride metformin tablet online", "dapagliflozin glimepiride metformin tablet price in india", "dapagliflozin glimepiride metformin tablet for uncontrolled diabetes", "dapagliflozin glimepiride metformin tablet triple therapy medicine", "dapagliflozin glimepiride metformin tablet dosage guide for adults" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcb453ba48b3ee8857fd47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate Monhydrate 64.25 mg, Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 1 mg", "description": "ST GLIPTIN GM is a high-quality, fixed-dose combination oral antidiabetic medication containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. This triple-combination therapy is specifically formulated to provide effective glycemic control in adults with type 2 diabetes mellitus (T2DM) who require multiple agents to achieve adequate blood sugar control.\nST GLIPTIN GM works through complementary mechanisms to target the core pathophysiological defects of T2DM—insulin resistance, impaired insulin secretion, and increased hepatic glucose output—making it an ideal choice for patients requiring intensified therapy.\nKey Indications:\nST GLIPTIN GM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when dual therapy with any two of the individual components (Sitagliptin, Metformin, or Glimepiride) does not provide adequate control.\nMechanism of Action:\nSitagliptin (50 mg):\nA Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the levels of active incretin hormones (GLP-1 and GIP), increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner.\nMetformin Hydrochloride (1000 mg):\nA biguanide that improves insulin sensitivity by decreasing hepatic glucose production and enhancing peripheral glucose uptake.\nGlimepiride (1 mg):\nA sulfonylurea that stimulates pancreatic β-cells to secrete insulin, thereby reducing blood glucose levels.\nThe combination targets multiple metabolic pathways to provide synergistic and sustained blood glucose control.\nDosage and Administration:\nRecommended Dose:\nOne tablet daily, preferably with meals to reduce gastrointestinal side effects.\nIndividualization Required:\nDosage should be tailored based on patient response, renal function, and physician assessment.\nRenal Monitoring:\nBaseline and periodic assessment of renal function is advised, particularly due to the metformin component.\nKey Benefits of ST GLIPTIN GM 50/1000/1:\nTriple Mechanism of Action:\nTargets insulin resistance, insufficient insulin secretion, and excessive hepatic glucose production.\nEnhanced Glycemic Control:\nEffective in achieving and maintaining HbA1c targets.\nOnce-Daily Convenience:\nImproves adherence by reducing pill burden in patients requiring combination therapy.\nWeight Neutral to Modest Reduction:\nMetformin and sitagliptin components support weight neutrality.\nLow Hypoglycemia Risk:\nSitagliptin and metformin carry minimal hypoglycemia risk; however, glimepiride may increase the risk—monitor accordingly.\nSafety and Precautions:\nHypoglycemia:\nMay occur, particularly due to the glimepiride component. Educate patients on recognizing and managing low blood sugar.\nLactic Acidosis:\nA rare but serious complication of metformin. Avoid in patients with significant renal impairment or conditions predisposing to hypoxia.\nRenal Function:\nDose adjustment or discontinuation may be needed based on renal function.\nPancreatitis:\nRare reports with DPP-4 inhibitors like sitagliptin. Discontinue if suspected.\nAllergic Reactions:\nDiscontinue use if hypersensitivity reactions occur.\nPossible Side Effects:\nWhile ST GLIPTIN GM is generally well-tolerated, some patients may experience:\nNausea\nDiarrhea\nHeadache\nHypoglycemia (especially in elderly or with missed meals)\nAbdominal discomfort\nUpper respiratory tract infections\nDizziness\nFlatulence\nIf any side effects persist or worsen, seek immediate medical advice.\nStorage Instructions:\nStore at a temperature below 30°C.\nProtect from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose ST GLIPTIN GM 50/1000/1?\nST GLIPTIN GM provides a powerful and synergistic combination of three well-established antidiabetic agents in a single, convenient daily dose. It offers a comprehensive approach to managing type 2 diabetes by addressing multiple metabolic abnormalities with a focus on safety, efficacy, and patient compliance. Manufactured under stringent GMP-certified conditions, ST GLIPTIN GM ensures quality, reliability, and therapeutic confidence for both patients and prescribers.", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2188, "imageuri": "https://productimages.withfloats.com/actual/68fcb456f31288eaa96accfa.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcb456f31288eaa96accfa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T11:28:19.425Z", "updatedon": "2026-03-13T10:40:20.1Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-phosphate-monhydrate-64-25-mg-sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-1-mg/2188", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+1", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg", "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg", "type 2 diabetes mellitus (T2DM)", "blood sugar control" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "681c5e9e5a26e4010ea42029", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin and metformin hydrochloride tablets", "description": "ST-GLIPTIN M 100/1000 is an advanced oral antidiabetic medication designed for the effective management of Type 2 Diabetes Mellitus. This powerful combination of Sitagliptin (100 mg) and Metformin Hydrochloride (1000 mg) offers dual action in controlling elevated blood glucose levels, especially in patients who do not respond adequately to metformin or sitagliptin alone. It is intended for adults and is generally used in conjunction with diet and exercise to enhance glycemic control.\n\nKey Ingredients\nSitagliptin (100 mg)\nSitagliptin is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor that increases the levels of incretin hormones, which help regulate blood sugar by increasing insulin release and decreasing glucagon levels.\n\nMetformin Hydrochloride (1000 mg)\nMetformin belongs to the biguanide class of antidiabetics. It works by reducing the amount of sugar produced by the liver and improves the body’s sensitivity to insulin, facilitating better glucose utilization.\n\nKey Benefits\nHelps reduce both fasting and postprandial (after-meal) blood glucose levels effectively\nImproves overall glycemic control in patients with Type 2 diabetes\nCombines two different mechanisms of action for better diabetes management\nMinimizes the risk of hypoglycemia compared to other antidiabetic therapies\nMay support weight neutrality or slight weight loss in diabetic individuals\n\nHow Does It Work?\nST-GLIPTIN M 100/1000 works through a synergistic mechanism by combining two effective antidiabetic agents:\n\nSitagliptin enhances the levels of incretin hormones, which help the pancreas produce more insulin and reduce the secretion of glucagon, especially when blood sugar is high.\nMetformin reduces hepatic glucose production and increases insulin sensitivity, which helps the body use glucose more efficiently.\nTogether, these agents provide comprehensive blood sugar control by addressing multiple physiological pathways involved in glucose metabolism.\n\nDirections for Use\nTake ST-GLIPTIN M 100/1000 exactly as prescribed by your physician.\nIt is typically taken once or twice daily with meals to reduce gastrointestinal side effects and optimize absorption.\nSwallow the tablet whole with water. Do not crush or chew the tablet.\nMaintain a balanced diet and follow an active lifestyle for best results.\nRegular blood sugar monitoring is essential to assess effectiveness and make any necessary dosage adjustments.\n\nSide Effects\nCommon side effects may include nausea, diarrhea, stomach upset, or headache.\nSome individuals may experience respiratory tract infections, sore throat, or a runny nose.\nLactic acidosis is a rare but serious side effect associated with high-dose metformin—seek immediate medical attention if symptoms like unusual fatigue, muscle pain, difficulty breathing, or abdominal discomfort occur.\nAllergic reactions such as rash, itching, or swelling are uncommon but possible.\nAlways inform your doctor of any persistent or bothersome side effects for timely intervention.", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "1001000 works", "100 1000stgliptin", "work stgliptin", "balanced diet", "tablet maintain", "diabetic individuals", "sitagliptin 100 mg", "timely intervention", "rash itching", "medical attention", "highdose metforminseek", "assess effectiveness", "active lifestyle", "pancreas produce", "synergistic mechanism", "antidiabetic therapies", "hypoglycemia compared", "glycemic control", "biguanide class", "incretin hormones", "respond adequately", "powerful combination", "insulin facilitating", "sugar produced", "side effect", "bodys sensitivity", "effective management", "blood sugar", "increases insulin sensitivity", "regulate blood sugar", "glucose metabolism directions", "increasing insulin release", "bothersome side effects", "diabetes management minimizes", "optimize absorption swallow", "slight weight loss", "support weight neutrality" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2107, "imageuri": "https://productimages.withfloats.com/actual/681c5e9f5e6dd8f19a0309c3.png", "tileimageuri": "https://productimages.withfloats.com/tile/681c5e9f5e6dd8f19a0309c3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-08T07:34:54.516Z", "updatedon": "2026-03-13T10:19:42.388Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-and-metformin-hydrochloride-tablets/2107", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST-GLIPTIN M 100/ 1000", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin and Metformin hydrochloride tablets Uses in Hindi", "sitagliptin and metformin hydrochloride tablets 50/1000 uses in hindi", "sitagliptin and metformin hydrochloride tablets", "sitagliptin and metformin hydrochloride uses in hindi", "sitagliptin and metformin hydrochloride uses", "sitagliptin and metformin hydrochloride tablets.", "sitagliptin and metformin tablets.", "sitagliptin and metformin combination.", "sitagliptin and metformin uses", "sitagliptin and metformin hydrochloride uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "681c57a735606e4776e9d16e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin and metformin hydrochloride tablets", "description": "ST-GLIPTIN M 100/500 is an oral antidiabetic medication designed to help manage Type 2 Diabetes Mellitus effectively. It combines two powerful ingredients, sitagliptin and metformin hydrochloride, which work together to help control blood sugar levels in adults.\n\nKey Ingredients:\n\nSitagliptin (100 mg): A DPP-4 inhibitor that helps increase the levels of incretin hormones, thereby stimulating insulin release and reducing glucose production by the liver.\n\nMetformin Hydrochloride (500 mg): A biguanide that improves insulin sensitivity and reduces hepatic glucose production.\n\nKey Benefits:\n\nHelps maintain healthy blood glucose levels.\n\nEnhances insulin sensitivity in the body.\n\nLowers glucose production in the liver.\n\nReduces the risks associated with high blood sugar, like cardiovascular complications.\n\nHow Does It Work?\nSitagliptin works by inhibiting the DPP-4 enzyme, which prolongs the activity of incretin hormones. These hormones help regulate blood sugar levels by increasing insulin release from the pancreas and decreasing glucagon levels. Metformin acts primarily by reducing the amount of sugar the liver produces and increasing the body's response to insulin. Together, they help achieve better glycemic control.\n\nDirections for Use:\nTake ST-GLIPTIN M 100/500 as prescribed by your healthcare professional. It is usually taken with meals to reduce gastrointestinal side effects. Do not skip doses and avoid self-adjusting the medication without consulting your doctor.\n\nSide Effects:\nSome common side effects may include:\n\nNausea or vomiting\n\nDiarrhea\n\nStomach upset\n\nHeadache\n\nSerious side effects are rare but may include lactic acidosis, allergic reactions, or severe hypoglycemia. Consult your healthcare provider immediately if you experience unusual symptoms.", "price": 182.0, "discountamount": 55.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "100 500stgliptin", "incretin hormones", "avoid selfadjusting", "skip doses", "bodys response", "liver produces", "dpp4 enzyme", "cardiovascular complications", "liver reduces", "helps increase", "dpp4 inhibitor", "metformin hydrochloride", "healthcare professional", "side effects", "increasing insulin release", "work sitagliptin works", "high blood sugar", "reducing glucose production", "common side effects", "doctor side effects", "healthcare provider immediately", "improves insulin sensitivity", "stimulating insulin release", "experience unusual symptoms", "severe hypoglycemia consult", "glycemic control directions", "powerful ingredients sitagliptin" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2106, "imageuri": "https://productimages.withfloats.com/actual/681c57a9d913fb8772192d78.png", "tileimageuri": "https://productimages.withfloats.com/tile/681c57a9d913fb8772192d78.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-08T07:05:11.998Z", "updatedon": "2026-03-13T10:17:07.531Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-and-metformin-hydrochloride-tablets/2106", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt. Ltd.", "category": "DIABETIC RANGE", "tags": [ "Type 2 Diabetes", "sitagliptin and metformin hydrochloride tablets", "blood sugar levels" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66619373ccd5ce1a10759768", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin and metformin hydrochloride tablets", "description": "ST-GLIPTIN 100 \nSitagliptin (100mg)\nIntroduction to ST-GLIPTIN 100\nST-GLIPTIN 100 contains Sitagliptin 100mg, a medication primarily used for the management of type 2 diabetes mellitus. Sitagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which help control blood sugar levels by enhancing the body’s own ability to regulate insulin after meals. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Sitagliptin?\nOverview of Sitagliptin\nSitagliptin is an oral diabetes medication that helps increase insulin production and decrease glucose production in the liver. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones. These hormones play a significant role in regulating glucose metabolism.\n\nMechanism of Action\nIncretin Hormones: Sitagliptin enhances the levels of incretin hormones, which increase insulin synthesis and release from pancreatic beta cells in response to meals.\nGlucose Regulation: It reduces the liver’s production of glucose, especially after meals, thereby helping to lower blood sugar levels.\nReduced Blood Sugar Spikes: By increasing insulin release and decreasing glucagon levels, Sitagliptin helps control blood sugar spikes after meals.\nBenefits of ST-GLIPTIN 100\nEffective Blood Sugar Management\nPostprandial Glucose Control: ST-GLIPTIN 100 helps manage postprandial (after-meal) blood sugar levels by enhancing the body’s natural response to meals.\nFasting Blood Sugar Control: It also helps in lowering fasting blood sugar levels, providing a balanced glycemic control throughout the day.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: ST-GLIPTIN 100 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nCombination Therapy: It can be used alone or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin for enhanced glycemic control.\nAdditional Health Benefits\nWeight Neutral: Sitagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nLow Risk of Hypoglycemia: When used alone, sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use ST-GLIPTIN 100\nDosage and Administration\nRecommended Dosage: The typical dosage of ST-GLIPTIN 100 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take ST-GLIPTIN 100 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now", "price": 450.0, "discountamount": 135.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "diet", "food", "body", "meals", "water", "liver", "drugs", "EMAIL", "Order", "class", "adults", "option", "Action", "ability", "Support", "Low Risk", "readings", "Overview", "patients", "same time", "Mechanism", "metformin", "full glass", "one tablet", "ST-GLIPTIN", "Guidelines", "Optimal Use", "weight gain", "Adjustments", "information", "sterisonline", "DPP-4 enzyme", "Introduction", "best results", "Hypoglycemia", "sterispharma", "sulfonylureas", "CALL/WHATSAPP", "typical dosage", "Administration", "Consistent Use", "treatment plan", "Weight Neutral", "insulin release", "glucagon levels", "Exercise Adjunct", "natural response", "significant role", "Sitagliptin 100mg", "insulin synthesis", "incretin hormones", "excellent adjunct", "Recommended Dosage", "glucose production", "insulin production", "prolonged activity", "Glucose Regulation", "glucose metabolism", "Blood Sugar Control", "Diabetes Management", "healthcare provider", "individual response", "Combination Therapy", "pancreatic beta cells", "lifestyle modifications", "meal) blood sugar levels", "oral diabetes medication", "type 2 diabetes mellitus", "balanced glycemic control", "enhanced glycemic control", "other diabetes medications", "Additional Health Benefits", "Reduced Blood Sugar Spikes", "Postprandial Glucose Control", "other antidiabetic medications", "Effective Blood Sugar Management", "dipeptidyl peptidase-4 (DPP-4) inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1454, "imageuri": "https://productimages.withfloats.com/actual/66619377e874b19df8bb10f6.png", "tileimageuri": "https://productimages.withfloats.com/tile/66619377e874b19df8bb10f6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:46:11.53Z", "updatedon": "2026-01-24T07:31:15.432Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-and-metformin-hydrochloride-tablets/1454", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST-GLIPTIN 100 ", "category": "DIABETIC RANGE", "tags": [ "ST-GLIPTIN 100", "Sitagliptin (100mg)", "Sitagliptin 100mg side effects", "Sitagliptin 100 mg price", "Sitagliptin 100 mg brands in India", "", "Sitagliptin 100 mg dose", "Sitagliptin 50" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665ef17474d94b15a06c31e2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gliclazide 40mg metformin 500 mg", "description": "GLICLAGLAZE M 40 \ngliclazide 40mg metformin 500 mg\nIntroduction\nGLICLAGLAZE M 40 is a combination medication designed to manage blood sugar levels in individuals with Type 2 diabetes. This oral treatment integrates two potent antidiabetic agents: Gliclazide (40 mg) and Metformin (500 mg), each playing a crucial role in diabetes control.\n\nHow It Works\n\nGliclazide (40 mg): As a sulfonylurea, Gliclazide works by stimulating the release of insulin from the pancreatic beta cells. Insulin is the hormone responsible for reducing blood glucose levels. Gliclazide also enhances the sensitivity of peripheral tissues to insulin and reduces the likelihood of clot formation, which is a common complication in diabetes patients.\nMetformin (500 mg): Metformin acts primarily by reducing glucose production in the liver. It also improves insulin sensitivity, enhancing peripheral glucose uptake and utilization. Unlike many other antidiabetic medications, Metformin does not cause hypoglycemia (low blood sugar) and is often associated with weight loss.\nBenefits\nThe dual mechanism of GLICLAGLAZE M 40 offers a comprehensive approach to diabetes management by not only improving insulin production and sensitivity but also addressing the hepatic release of glucose. This combination reduces blood sugar levels effectively while minimizing the risk of side effects common to other diabetes treatments, such as hypoglycemia.\n\nUsage Guidelines\n\nDosage: Typically, the initial dosage is guided by the patient’s current treatment regimen, effectiveness, and tolerability. Adjustment in dosage should be made based on the patient’s blood glucose response, under the supervision of a healthcare provider.\nAdministration: GLICLAGLAZE M 40 should be taken with meals to reduce gastrointestinal side effects and to enhance absorption.\nSide Effects\nWhile GLICLAGLAZE M 40 is generally well-tolerated, it may cause some side effects. Common ones include gastrointestinal disturbances such as nausea and diarrhea, which are often transient. Hypoglycemia may occur, but it is less frequent due to the mitigating action of Metformin.\n\nConclusion\nGLICLAGLAZE M 40 is a cornerstone in the pharmacological treatment of Type 2 diabetes, offering benefits derived from the combined effects of Gliclazide and Metformin. It is essential for patients to follow their healthcare provider’s instructions and to maintain regular check-ups to optimize treatment outcomes and prevent complications. This medication enables patients to manage their diabetes more effectively and improve their quality of life.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n Order Now\n\n\n\n\n\n\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "risk", "liver", "meals", "40 mg", "Order", "EMAIL", "500 mg", "nausea", "quality", "hormone", "diarrhea", "Benefits", "Metformin", "gliclazide", "Adjustment", "likelihood", "Conclusion", "absorption", "utilization", "cornerstone", "information", "supervision", "individuals", "weight loss", "sulfonylurea", "hypoglycemia", "Introduction", "tolerability", "sterisonline", "instructions", "sterispharma", "crucial role", "complications", "GLICLAGLAZE M", "CALL/WHATSAPP", "effectiveness", "oral treatment", "dual mechanism", "clot formation", "Administration", "initial dosage", "Type 2 diabetes", "hepatic release", "low blood sugar", "diabetes control", "combined effects", "mitigating action", "diabetes patients", "regular check-ups", "blood sugar levels", "treatment outcomes", "peripheral tissues", "glucose production", "insulin production", "diabetes management", "insulin sensitivity", "common complication", "healthcare provider", "blood glucose levels", "pancreatic beta cells", "combination medication", "blood glucose response", "comprehensive approach", "Usage Guidelines Dosage", "pharmacological treatment", "peripheral glucose uptake", "current treatment regimen", "other diabetes treatments", "gastrointestinal disturbances", "gastrointestinal side effects", "two potent antidiabetic agents", "many other antidiabetic medications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1284, "imageuri": "https://productimages.withfloats.com/actual/665ef175c06ee12d88caa810.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef175c06ee12d88caa810.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T10:50:28.577Z", "updatedon": "2026-03-13T05:35:17.063Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclazide-40mg-metformin-500-mg/1284", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE M 40 ", "category": "DIABETIC RANGE", "tags": [ "gliclazide 40mg metformin 500 mg tablet uses", "gliclazide 40mg metformin 500 mg dosage for diabetes", "gliclazide metformin 40 mg 500 mg side effects", "gliclazide 40mg metformin 500 mg tablet for type 2 diabetes", "gliclazide metformin combination tablet information", "gliclazide metformin 40mg 500mg blood sugar control", "buy gliclazide 40mg metformin 500 mg tablets online", "order gliclazide metformin tablets online india", "gliclazide metformin bulk purchase online", "gliclazide 40mg metformin 500 mg uses dosage and side effects", "buy gliclazide 40mg metformin 500 mg tablets online best price", "gliclazide 40mg metformin 500 mg price in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "69ba6804c567eee0a8f28929", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin hydrochloride prolonged release and glimepiride tablets", "description": "Managing blood sugar levels effectively is essential for leading a healthy and active life, especially for individuals living with Type 2 Diabetes. With changing lifestyles, unhealthy eating habits, and rising stress levels, diabetes has become increasingly common. To address this, combination therapies like SEIZMET G3 850 offer a powerful and balanced approach to blood sugar control.\n\nThis article provides a detailed, human-friendly, and SEO-optimized guide to Metformin Hydrochloride Prolonged Release and Glimepiride Tablets, marketed under the brand name SEIZMET G3 850.\n\nWhat is SEIZMET G3 850?\n\nSEIZMET G3 850 is a combination anti-diabetic medication that contains:\n\nMetformin Hydrochloride (Prolonged Release) – 850 mg\n\nGlimepiride – 3 mg\n\nThis dual-action formula is designed to control high blood sugar levels in patients with Type 2 Diabetes by targeting different mechanisms in the body.\n\nHow Does SEIZMET G3 850 Work?\n\nThis medicine works through a combination of two powerful components:\n\n1. Metformin (Prolonged Release)\n\nMetformin helps:\n\nReduce glucose production in the liver\n\nImprove insulin sensitivity\n\nEnhance glucose absorption by cells\n\nThe prolonged-release formulation ensures gradual and sustained action, reducing side effects and improving patient compliance.\n\n2. Glimepiride\n\nGlimepiride works by:\n\nStimulating the pancreas to release insulin\n\nImproving the body’s ability to utilize insulin\n\nTogether, these ingredients provide comprehensive blood sugar control throughout the day.\n\nUses of SEIZMET G3 850\n\nSEIZMET G3 850 is primarily used for:\n\n✔ Management of Type 2 Diabetes\n\nIt helps control high blood sugar levels when diet and exercise alone are not sufficient.\n\n✔ Improving Glycemic Control\n\nIt stabilizes blood glucose fluctuations and prevents sudden spikes.\n\n✔ Reducing Risk of Complications\n\nProper diabetes management reduces the risk of:\n\nHeart disease\n\nKidney damage\n\nNerve problems\n\nVision issues\n\nKey Benefits of SEIZMET G3 850\n1. Dual Action Formula\n\nCombines two effective drugs to target diabetes from multiple angles.\n\n2. Sustained Blood Sugar Control\n\nThe prolonged-release metformin ensures steady glucose control throughout the day.\n\n3. Improved Insulin Function\n\nEnhances insulin sensitivity and promotes better glucose utilization.\n\n4. Convenient Dosage\n\nSingle tablet combination reduces pill burden and improves adherence.\n\n5. Weight Neutral Effect\n\nMetformin may help prevent weight gain often associated with diabetes medications.\n\n6. Cardiovascular Protection\n\nHelps reduce the risk of heart-related complications in diabetic patients.\n\nDosage and Administration\n\nAlways take SEIZMET G3 850 as prescribed by your doctor\n\nUsually taken once daily with meals\n\nSwallow the tablet whole—do not crush or chew\n\nMaintain a balanced diet and regular exercise routine\n\nPossible Side Effects\n\nLike all medications, SEIZMET G3 850 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nHeadache\n\nDizziness\n\nThese are usually mild and improve as your body adjusts to the medication.\n\nSerious Side Effects (Rare but Important):\n\nLow blood sugar (hypoglycemia)\n\nLactic acidosis (a rare but serious condition linked to metformin)\n\nAllergic reactions (rash, swelling, itching)\n\nSeek immediate medical attention if you experience severe symptoms.\n\nPrecautions and Warnings\n\nBefore taking SEIZMET G3 850, inform your doctor if you have:\n\nKidney or liver disease\n\nHeart conditions\n\nHistory of alcohol abuse\n\nVitamin B12 deficiency\n\nImportant Tips:\n\nAvoid excessive alcohol consumption\n\nMonitor blood sugar regularly\n\nFollow a diabetic-friendly diet\n\nInform your doctor about other medications\n\nWho Should Avoid This Medicine?\n\nSEIZMET G3 850 may not be suitable for:\n\nPatients with severe kidney disease\n\nIndividuals with Type 1 Diabetes\n\nPregnant or breastfeeding women (unless prescribed)\n\nPeople with known allergies to its components\n\nLifestyle Tips for Better Results\n\nMedication works best when combined with a healthy lifestyle:\n\n✔ Balanced Diet\nInclude:\nWhole grains\nVegetables\n\nLean protein\n\nAvoid sugary and processed foods.\n\n✔ Regular Exercise\n\nAt least 30 minutes of daily activity helps improve insulin sensitivity.\n\n✔ Stress Management\n\nStress can increase blood sugar levels—practice meditation or yoga.\n\n✔ Routine Checkups\n\nRegular monitoring ensures better control and prevents complications.\n\nWhy Choose the SEIZMET G3 850?\n\nChoosing the right medication is crucial in diabetes management. SEIZMET G3 850 stands out because:\n\nIt combines trusted and proven ingredients\n\nOffers long-lasting glucose control\n\nImproves overall metabolic health\n\nSupports a better quality of life\n\nConclusion\nLiving with type 2 diabetes can be challenging, but with the right treatment and lifestyle choices, it can be effectively managed.", "price": 112.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2338, "imageuri": "https://productimages.withfloats.com/actual/69ba680714005fb7b0e65883.png", "tileimageuri": "https://productimages.withfloats.com/tile/69ba680714005fb7b0e65883.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-18T08:53:24.979Z", "updatedon": "2026-03-18T09:03:56.284Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/metformin-hydrochloride-prolonged-release-and-glimepiride-tablets/2338", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET G3 850", "category": "DIABETIC RANGE", "tags": [ "metformin prolonged release and glimepiride tablets uses", "glimepiride with metformin sr tablets benefits", "metformin hydrochloride pr and glimepiride combination", "metformin sr and glimepiride tablets dosage guide", "glimepiride metformin tablets for type 2 diabetes", "metformin glimepiride combination therapy benefits", "metformin glimepiride tablets for sugar control", "tablets for type 2 diabetes control india", "best medicine for high blood sugar type 2", "combination tablets for diabetes management", "what is metformin hydrochloride prolonged release", "how to control blood sugar with oral tablets", "order metformin glimepiride tablets online india", "glimepiride and metformin tablets manufacturer india", "where to buy diabetes tablets metformin glimepiride", "prescription tablets for type 2 diabetes buy online", "metformin 850 glimepiride 3mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }